+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Azithromycin Market by Product Type (Branded, Generic), Dosage Form (Capsule, Suspension, Tablet), Route of Administration, Indication, End User, Sales Channel - Global Forecast 2025-2030- Product Image
Azithromycin Market by Product Type (Branded, Generic), Dosage Form (Capsule, Suspension, Tablet), Route of Administration, Indication, End User, Sales Channel - Global Forecast 2025-2030- Product Image
Sale

Azithromycin Market by Product Type (Branded, Generic), Dosage Form (Capsule, Suspension, Tablet), Route of Administration, Indication, End User, Sales Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 182 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082440
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global azithromycin market is evolving rapidly amidst shifting antibiotic usage paradigms, regulatory changes, and manufacturing innovation. As healthcare systems navigate increasing microbial threats, azithromycin’s role continues to adapt, influencing both patient outcomes and strategic decision-making for industry leaders.

Market Snapshot: Azithromycin Market Size and Growth

The azithromycin market grew from USD 7.40 billion in 2024 to USD 7.83 billion in 2025. It is expected to continue expanding at a compound annual growth rate (CAGR) of 5.72%, reaching USD 10.34 billion by 2030. This progression reflects sustained demand across key regions and applications within the antibiotic segment.

Scope & Segmentation

This research provides a complete overview of the azithromycin market, analyzing critical segments and technologies that influence product adoption and commercial strategy. Key segmentation points include the following:

  • Product Types: Branded, Generic
  • Dosage Forms: Capsule, Suspension, Tablet
  • Routes of Administration: Intravenous, Oral
  • Indications:
    • Gastrointestinal Infections – Traveler’s Diarrhea
    • Respiratory Infections – Lower and Upper Respiratory
    • Sexually Transmitted Infections – Chlamydia, Gonorrhea
    • Skin Infections – Acute bacterial skin and soft tissue
  • End Users: Ambulatory Care, Clinics, Homecare, Hospitals
  • Sales Channels: Drug Store, Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
  • Regions:
    • Americas – United States (including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio), Canada, Mexico, Brazil, Argentina
    • Europe, Middle East & Africa – United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland
    • Asia-Pacific – China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan
  • Technologies: Nanotechnology-driven drug delivery, Sustained-release formulations, Digital health adherence platforms
  • Key Companies: Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Viatris Inc., Hikma Pharmaceuticals PLC, Zydus Lifesciences Ltd., Lupin Limited, Sun Pharmaceutical Industries Ltd.

Key Takeaways for Decision-Makers

  • Broader adoption of azithromycin is supported by its convenient dosing and versatile clinical applications, driving its continued relevance across multiple indications.
  • Competitive differentiation between branded and generic formulations shapes portfolio strategy and pricing, with generics leveraging established regulatory pathways while brands focus on innovation in delivery and support.
  • Technological advances, such as nanoparticle carriers and digital adherence tracking, are enhancing patient compliance and targeted therapy outcomes.
  • Regional market diversity is fueled by local regulatory environments and healthcare infrastructure maturity, influencing both availability and uptake of intravenous versus oral forms.
  • Strategic partnerships and licensing agreements are propelling geographic expansion and R&D collaboration, particularly in emerging and rapidly scaling Asia-Pacific markets.
  • Manufacturers are strengthening supply chain resilience through diversified sourcing and inventory synchronization, addressing disruptions and ensuring reliable patient access.

Tariff Impact on Supply Chain and Strategy

The 2025 United States tariff adjustments significantly altered input costs and distribution logistics for azithromycin manufacturers. Companies have responded by implementing nearshoring initiatives, renegotiating supplier agreements, and diversifying sourcing strategies to mitigate both financial and operational exposure. Enhanced risk management and supply continuity efforts are now central to maintaining uninterrupted market access and optimizing distribution in the face of regulatory and customs complexities.

Methodology & Data Sources

This market analysis integrates structured interviews with key opinion leaders, clinicians, supply chain experts, and regulatory professionals. Quantitative data were cross-referenced with clinical trial registries and pharmacovigilance databases, while qualitative insights were synthesized through thematic review. Established frameworks such as SWOT and Porter’s Five Forces underpinned market entry and supply chain dynamics assessments, ensuring methodological rigor and transparency.

Why This Report Matters

  • Delivers actionable insights for benchmarking strategic decisions related to market entry, product development, and supply chain optimization in the antibiotic sector.
  • Equips pharmaceutical executives and healthcare stakeholders with a clear orientation to evolving treatment trends, regulatory changes, and technological advancements relevant to azithromycin.
  • Supports preparation for policy shifts and operational challenges in diverse regional markets, driving forward-looking business development initiatives.

Conclusion

The azithromycin market is defined by evolving clinical expectations, regulatory change, and manufacturing advancements. Informed strategy and agile adaptation will empower decision-makers to optimize value and resilience amid ongoing transformation.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Surge in azithromycin generic competition driving price erosion in mature markets due to multiple API manufacturers
5.2. Rising antibiotic stewardship regulations limiting inappropriate azithromycin prescriptions in hospital settings
5.3. Expansion of azithromycin distribution in emerging markets amid growing respiratory infection prevalence
5.4. Advances in extended-release azithromycin formulations improving patient adherence in outpatient treatments
5.5. Supply chain disruptions in active pharmaceutical ingredients impacting azithromycin availability globally
5.6. Growing off-label research on azithromycin in viral co-infection therapies post-COVID-19 pandemic
5.7. Integration of digital adherence tools to monitor patient compliance with azithromycin regimens
5.8. Environmental sustainability initiatives targeting reduction of azithromycin manufacturing effluent contamination
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Azithromycin Market, by Product Type
8.1. Introduction
8.2. Branded
8.3. Generic
9. Azithromycin Market, by Dosage Form
9.1. Introduction
9.2. Capsule
9.3. Suspension
9.4. Tablet
10. Azithromycin Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Azithromycin Market, by Indication
11.1. Introduction
11.2. Gastrointestinal Infections
11.2.1. Travelers Diarrhea
11.3. Respiratory Infections
11.3.1. Lower Respiratory Infections
11.3.2. Upper Respiratory Infections
11.4. Sexually Transmitted Infections
11.4.1. Chlamydia Infections
11.4.2. Gonorrhea
11.5. Skin Infections
11.5.1. Acute Bacterial Skin Structure Infections
11.5.2. Soft Tissue Infections
12. Azithromycin Market, by End User
12.1. Introduction
12.2. Ambulatory Care
12.3. Clinics
12.4. Homecare
12.5. Hospitals
13. Azithromycin Market, by Sales Channel
13.1. Introduction
13.2. Drug Store
13.3. Hospital Pharmacy
13.4. Online Pharmacy
13.5. Retail Pharmacy
14. Americas Azithromycin Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Azithromycin Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Azithromycin Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Pfizer Inc.
17.3.2. Teva Pharmaceutical Industries Ltd.
17.3.3. Sandoz International GmbH
17.3.4. Cipla Ltd.
17.3.5. Dr. Reddy's Laboratories Ltd.
17.3.6. Viatris Inc.
17.3.7. Hikma Pharmaceuticals PLC
17.3.8. Zydus Lifesciences Ltd.
17.3.9. Lupin Limited
17.3.10. Sun Pharmaceutical Industries Ltd.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. AZITHROMYCIN MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. AZITHROMYCIN MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. AZITHROMYCIN MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. AZITHROMYCIN MARKET: RESEARCHAI
FIGURE 28. AZITHROMYCIN MARKET: RESEARCHSTATISTICS
FIGURE 29. AZITHROMYCIN MARKET: RESEARCHCONTACTS
FIGURE 30. AZITHROMYCIN MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. AZITHROMYCIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL AZITHROMYCIN MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL AZITHROMYCIN MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL AZITHROMYCIN MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL AZITHROMYCIN MARKET SIZE, BY BRANDED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL AZITHROMYCIN MARKET SIZE, BY GENERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL AZITHROMYCIN MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL AZITHROMYCIN MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL AZITHROMYCIN MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL AZITHROMYCIN MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL AZITHROMYCIN MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL AZITHROMYCIN MARKET SIZE, BY TRAVELERS DIARRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL AZITHROMYCIN MARKET SIZE, BY TRAVELERS DIARRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL AZITHROMYCIN MARKET SIZE, BY LOWER RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL AZITHROMYCIN MARKET SIZE, BY UPPER RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL AZITHROMYCIN MARKET SIZE, BY CHLAMYDIA INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL AZITHROMYCIN MARKET SIZE, BY GONORRHEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL AZITHROMYCIN MARKET SIZE, BY ACUTE BACTERIAL SKIN STRUCTURE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL AZITHROMYCIN MARKET SIZE, BY SOFT TISSUE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL AZITHROMYCIN MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL AZITHROMYCIN MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOMECARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL AZITHROMYCIN MARKET SIZE, BY DRUG STORE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL AZITHROMYCIN MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL AZITHROMYCIN MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL AZITHROMYCIN MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES AZITHROMYCIN MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 128. CANADA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 129. CANADA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. CANADA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. CANADA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. CANADA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. CANADA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 134. CANADA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 135. CANADA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 136. CANADA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 137. CANADA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 138. CANADA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 139. CANADA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 140. CANADA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 141. CANADA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. CANADA AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. CANADA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. CANADA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. MEXICO AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. MEXICO AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. MEXICO AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. MEXICO AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. MEXICO AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 152. MEXICO AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 153. MEXICO AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 154. MEXICO AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 155. MEXICO AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 156. MEXICO AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 157. MEXICO AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 158. MEXICO AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 159. MEXICO AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 160. MEXICO AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 161. MEXICO AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. MEXICO AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. MEXICO AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. MEXICO AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA AZITHROMYCIN MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. GERMANY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 250. GERMANY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 251. GERMANY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. GERMANY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. GERMANY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 254. GERMANY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 255. GERMANY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 256. GERMANY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 257. GERMANY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 258. GERMANY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 259. GERMANY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 260. GERMANY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 261. GERMANY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 262. GERMANY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 263. GERMANY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. GERMANY AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. GERMANY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. GERMANY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. FRANCE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. FRANCE AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. FRANCE AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 272. FRANCE AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 273. FRANCE AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. FRANCE AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. FRANCE AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 276. FRANCE AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 277. FRANCE AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 278. FRANCE AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 279. FRANCE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 280. FRANCE AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 281. FRANCE AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 282. FRANCE AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 283. FRANCE AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. FRANCE AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. FRANCE AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 286. FRANCE AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 287. RUSSIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 288. RUSSIA AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 289. RUSSIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 290. RUSSIA AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 291. RUSSIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 292. RUSSIA AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 293. RUSSIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 294. RUSSIA AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 295. RUSSIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 296. RUSSIA AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 297. RUSSIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 298. RUSSIA AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 299. RUSSIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 300. RUSSIA AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 301. RUSSIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 302. RUSSIA AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 303. RUSSIA AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 304. RUSSIA AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 305. RUSSIA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 306. RUSSIA AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 307. ITALY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. ITALY AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. ITALY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 310. ITALY AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 311. ITALY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 312. ITALY AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 313. ITALY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. ITALY AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. ITALY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 316. ITALY AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 317. ITALY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 318. ITALY AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 319. ITALY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 320. ITALY AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 321. ITALY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 322. ITALY AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 323. ITALY AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. ITALY AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. ITALY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. ITALY AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. SPAIN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 328. SPAIN AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 329. SPAIN AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 330. SPAIN AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 331. SPAIN AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 332. SPAIN AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 333. SPAIN AZITHROMYCIN MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 334. SPAIN AZITHROMYCIN MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 335. SPAIN AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2018-2024 (USD MILLION)
TABLE 336. SPAIN AZITHROMYCIN MARKET SIZE, BY GASTROINTESTINAL INFECTIONS, 2025-2030 (USD MILLION)
TABLE 337. SPAIN AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 338. SPAIN AZITHROMYCIN MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 339. SPAIN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2018-2024 (USD MILLION)
TABLE 340. SPAIN AZITHROMYCIN MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTIONS, 2025-2030 (USD MILLION)
TABLE 341. SPAIN AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2018-2024 (USD MILLION)
TABLE 342. SPAIN AZITHROMYCIN MARKET SIZE, BY SKIN INFECTIONS, 2025-2030 (USD MILLION)
TABLE 343. SPAIN AZITHROMYCIN MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 344. SPAIN AZITHROMYCIN MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 345. SPAIN AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. SPAIN AZITHROMYCIN MARKET SIZE, BY SALES CHANNEL, 2025-2030 (USD MILLION)
TABLE 347. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 348. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 349. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 350. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 351. UNITED ARAB EMIRATES AZITHROMYCIN MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TAB

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Azithromycin market report include:
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Cipla Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Viatris Inc.
  • Hikma Pharmaceuticals PLC
  • Zydus Lifesciences Ltd.
  • Lupin Limited
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 7.83 Billion
Forecasted Market Value ( USD ) by 2030 $ 10.34 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Azithromycin Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 90 Pages
  • Global
From
Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F - Product Image

Azithromycin Dihydrate Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2035F

  • Report
  • 183 Pages
  • Global
From
Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Azithromycin (CAS 83905-01-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Macrolide Antibiotics Market Report 2025 - Product Image

Macrolide Antibiotics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Azithromycin Market

Azithromycin is an antibiotic used to treat a wide range of bacterial infections. It is a macrolide-type antibiotic, which works by stopping the growth of bacteria. Azithromycin is commonly used to treat respiratory infections, skin infections, ear infections, and sexually transmitted diseases. It is also used to prevent certain bacterial infections in people with weakened immune systems. Azithromycin is available in both oral and intravenous forms, and is often prescribed in combination with other antibiotics. Azithromycin is one of the most widely prescribed antibiotics in the world. It is generally well-tolerated and has a low risk of side effects. It is also relatively inexpensive, making it an attractive option for many patients. The azithromycin market is highly competitive, with many companies offering generic versions of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, Sanofi, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.